Get Premium to unlock powerful stock data

PFM Health Sciences, LP Buys Erasca Inc, Caribou Biosciences Inc, Cytokinetics Inc, Sells , ACADIA Pharmaceuticals Inc, Myovant Sciences

Author's Avatar
insider
Nov 16, 2021
Article's Main Image
Investment company PFM Health Sciences, LP (Current Portfolio) buys Erasca Inc, Caribou Biosciences Inc, Cytokinetics Inc, Sophia Genetics SA, AstraZeneca PLC, sells , ACADIA Pharmaceuticals Inc, Myovant Sciences, Biogen Inc, Baxter International Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, PFM Health Sciences, LP. As of 2021Q3, PFM Health Sciences, LP owns 80 stocks with a total value of $3.2 billion. These are the details of the buys and sells.

For the details of PFM Health Sciences, LP's stock buys and sells, go to https://www.gurufocus.com/guru/pfm+health+sciences%2C+lp/current-portfolio/portfolio

These are the top 5 holdings of PFM Health Sciences, LP
  1. Horizon Therapeutics PLC (HZNP) - 1,561,290 shares, 5.31% of the total portfolio. Shares reduced by 1.64%
  2. Outset Medical Inc (OM) - 2,966,712 shares, 4.55% of the total portfolio.
  3. Eli Lilly and Co (LLY) - 525,455 shares, 3.77% of the total portfolio.
  4. Arcus Biosciences Inc (RCUS) - 3,431,010 shares, 3.72% of the total portfolio. Shares reduced by 1.92%
  5. Cytokinetics Inc (CYTK) - 3,159,701 shares, 3.51% of the total portfolio. Shares added by 87.30%
New Purchase: Erasca Inc (ERAS)

PFM Health Sciences, LP initiated holding in Erasca Inc. The purchase prices were between $17.43 and $24.34, with an estimated average price of $20.69. The stock is now traded at around $19.550000. The impact to a portfolio due to this purchase was 3.05%. The holding were 5,191,405 shares as of 2021-09-30.

New Purchase: Caribou Biosciences Inc (CRBU)

PFM Health Sciences, LP initiated holding in Caribou Biosciences Inc. The purchase prices were between $15.75 and $30.29, with an estimated average price of $24.56. The stock is now traded at around $21.530000. The impact to a portfolio due to this purchase was 2.74%. The holding were 4,092,309 shares as of 2021-09-30.

New Purchase: Sophia Genetics SA (SOPH)

PFM Health Sciences, LP initiated holding in Sophia Genetics SA. The purchase prices were between $15.18 and $19.77, with an estimated average price of $17.62. The stock is now traded at around $15.510000. The impact to a portfolio due to this purchase was 1.1%. The holding were 2,022,552 shares as of 2021-09-30.

New Purchase: Catalent Inc (CTLT)

PFM Health Sciences, LP initiated holding in Catalent Inc. The purchase prices were between $109.17 and $142.35, with an estimated average price of $124.9. The stock is now traded at around $131.400000. The impact to a portfolio due to this purchase was 0.73%. The holding were 177,800 shares as of 2021-09-30.

New Purchase: IVERIC bio Inc (ISEE)

PFM Health Sciences, LP initiated holding in IVERIC bio Inc. The purchase prices were between $7.07 and $17.5, with an estimated average price of $10.82. The stock is now traded at around $16.480000. The impact to a portfolio due to this purchase was 0.57%. The holding were 1,138,112 shares as of 2021-09-30.

New Purchase: Stevanato Group SPA (STVN)

PFM Health Sciences, LP initiated holding in Stevanato Group SPA. The purchase prices were between $19.51 and $28.7, with an estimated average price of $23.62. The stock is now traded at around $22.050000. The impact to a portfolio due to this purchase was 0.43%. The holding were 549,002 shares as of 2021-09-30.

Added: Cytokinetics Inc (CYTK)

PFM Health Sciences, LP added to a holding in Cytokinetics Inc by 87.30%. The purchase prices were between $18.54 and $35.74, with an estimated average price of $29.35. The stock is now traded at around $39.240000. The impact to a portfolio due to this purchase was 1.64%. The holding were 3,159,701 shares as of 2021-09-30.

Added: AstraZeneca PLC (AZN)

PFM Health Sciences, LP added to a holding in AstraZeneca PLC by 276.68%. The purchase prices were between $55.56 and $60.79, with an estimated average price of $58.25. The stock is now traded at around $57.630000. The impact to a portfolio due to this purchase was 1.08%. The holding were 785,748 shares as of 2021-09-30.

Added: Thermo Fisher Scientific Inc (TMO)

PFM Health Sciences, LP added to a holding in Thermo Fisher Scientific Inc by 105.12%. The purchase prices were between $509.53 and $609.78, with an estimated average price of $548.6. The stock is now traded at around $641.480000. The impact to a portfolio due to this purchase was 0.65%. The holding were 71,442 shares as of 2021-09-30.

Added: Penumbra Inc (PEN)

PFM Health Sciences, LP added to a holding in Penumbra Inc by 32.39%. The purchase prices were between $250.72 and $291.24, with an estimated average price of $268.99. The stock is now traded at around $265.420000. The impact to a portfolio due to this purchase was 0.36%. The holding were 177,088 shares as of 2021-09-30.

Added: Novavax Inc (NVAX)

PFM Health Sciences, LP added to a holding in Novavax Inc by 32.26%. The purchase prices were between $177.8 and $270.58, with an estimated average price of $220.82. The stock is now traded at around $170.490000. The impact to a portfolio due to this purchase was 0.31%. The holding were 197,208 shares as of 2021-09-30.

Added: Heron Therapeutics Inc (HRTX)

PFM Health Sciences, LP added to a holding in Heron Therapeutics Inc by 36.13%. The purchase prices were between $10.13 and $15, with an estimated average price of $12.21. The stock is now traded at around $11.240000. The impact to a portfolio due to this purchase was 0.26%. The holding were 2,993,546 shares as of 2021-09-30.

Sold Out: (ALXN)

PFM Health Sciences, LP sold out a holding in . The sale prices were between $179.45 and $186.61, with an estimated average price of $183.84.

Sold Out: ACADIA Pharmaceuticals Inc (ACAD)

PFM Health Sciences, LP sold out a holding in ACADIA Pharmaceuticals Inc. The sale prices were between $15.78 and $24.77, with an estimated average price of $19.31.

Sold Out: Myovant Sciences Ltd (MYOV)

PFM Health Sciences, LP sold out a holding in Myovant Sciences Ltd. The sale prices were between $18.94 and $26.99, with an estimated average price of $22.04.

Sold Out: Baxter International Inc (BAX)

PFM Health Sciences, LP sold out a holding in Baxter International Inc. The sale prices were between $73.77 and $83.61, with an estimated average price of $79.12.

Sold Out: Arena Pharmaceuticals Inc (ARNA)

PFM Health Sciences, LP sold out a holding in Arena Pharmaceuticals Inc. The sale prices were between $45.8 and $71.24, with an estimated average price of $59.26.

Sold Out: Laboratory Corp of America Holdings (LH)

PFM Health Sciences, LP sold out a holding in Laboratory Corp of America Holdings. The sale prices were between $274.82 and $308.34, with an estimated average price of $293.32.



Here is the complete portfolio of PFM Health Sciences, LP. Also check out:

1. PFM Health Sciences, LP's Undervalued Stocks
2. PFM Health Sciences, LP's Top Growth Companies, and
3. PFM Health Sciences, LP's High Yield stocks
4. Stocks that PFM Health Sciences, LP keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus